AbbVie Baxter Golden Cross: One Signal Proves Real
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
A batch of midweek analyst notes lifts several big names, steering markets higher as investors weigh price targets, e...
Texas Instruments preps for July earnings with a guidance-led breakout in industrial and data-center demand, plus a f...
With American Express set to report on July 24, analysts say a durable franchise, disciplined capital returns, and a ...
Morgan Stanley reveals a sharper cost curve for AI data centers, suggesting only a few players can fund the next wave...
In 2025, the U.S. minted 441,000 new millionaires as the median American wealth contracted, underscoring a split econ...
Analysts model a five-year horizon for Broadcom, showing a pathway where a $5,000 stake could grow significantly by 2...
As Verizon nears its July 24 earnings, investors are eyeing a potential near-25% upside driven by steady cash flow, a...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Two retirees with identical $1.5 million portfolios may see thousands more in annual costs simply because they live i...
As market volatility persists in mid-2026, five high-quality dividend stocks appear especially compelling for income ...
Jim Cramer challenges a fresh downgrade on Apple, arguing the stock’s AI ambitions and a possible 2027 supercycle jus...